Categorical Course

Interventional Oncology

Interventional Oncology 2

Coordinator(s)

• PP

  Philippe Pereira, MD, PhD (he/him/his)

  Advisor
  SLK Kliniken gGmbH Heilbronn, Germany
• 

  Jordan Tasse, MD

  Associate professor of interventional radiology/Director of interventional oncology
  Rush University Medical Center, United States

„To explore the increasing role of local therapies in liver tumors and the importance to integrate IO into clinical care“

Presentations:

• 9:45 AM - 9:54 AM ET

  European IO: Evolution of Locoregional HCC in Europe
  

  Speaker: Philippe L. Pereira, MD, PhD (he/him/his) – SLK Kliniken gGmbH Heilbronn
• 9:54 AM - 10:03 AM ET

  Fibrolamellar HCC: How is IR an Integral Part of Care
  

  Speaker: Jordan Tasse, MD – Rush University Medical Center
• 10:03 AM - 10:12 AM ET

  Integrating TACE, With (PD-[L]1 Inhibitors, and MTT In HCC
  

  Speaker: Hai-Dong Zhu, MD, PhD (he/him/his) – Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University
• 10:12 AM - 10:21 AM ET

  Ablation vs Surgery: Dissecting COLLISION Study
• 10:21 AM - 10:30 AM ET

  IR's Growing Role and Integration Into Clinical Care in A Busy Cancer Hospital
• 10:30 AM - 10:39 AM ET

  Streamlining and Same-Day Radioembolization with Resin Microspheres
  

  Speaker: Hyo-Cheol Kim, MD – Seoul National University Hospital
• 10:39 AM - 10:48 AM ET

  Locally Late-stage HCC: Integrating HAIC into First-line Treatment
  

  Speaker: Haibo Shao, MD, PhD – The First Hospital of China Medical University
• 10:48 AM - 11:00 AM ET

  Q&A